Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura

Journal of Clinical Immunology

Volumn 27, Issue 6, 2007, Pages 557-562

  Guo, Chengshan ^a   Chu, Xiaoxia ^b   Shi, Yan ^c   He, Weidong ^d   Li, Lizhen ^c   Wang, Lin ^c   Wang, Yingxue ^a   Peng, Jun ^c   Hou, Ming ^c  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

^d Shandong Blood Center   (China)

Author keywords

Cytokines; Dexamethasone; Idiopathic thrombocytophenic purpura; T helper lymphocyte

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; DEXAMETHASONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHRONIC DISEASE; DRUG EFFECT; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; TH1 CELL;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; CYTOKINES; DEXAMETHASONE; FEMALE; HUMANS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TH1 CELLS;

EID: 38649109517     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9111-1     Document Type: Article

References (28)

1. Kuwana M, Kaburaki J Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of anti-platelet autoantibody. J Clin Invest 1998;102:1393-402. (Pubitemid 28467568)
2. Hedlund-Treutiger I, Wahlstrom J, Elinder G. Role of the T cell receptor in idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998;424:46-50. (Pubitemid 28410860)
3. Semple JW, Lazarus AH, Freedman J. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update. Transfus Sci 1998;19:245-51.
4. Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005;56:425-42. (Pubitemid 40299791)
5. Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991;78:2619-25.
6. Garcia-Suarez J, Prieto A, Reye E, Manzano L, Merino JL, Alvarez-Mon M. The clinical outcome of autoimmune thrombocytopenic purpura is related to their T-cell immunodeficiency. Br J Haematol 1993;84:464-70. (Pubitemid 23224163)
7. Ware RE, Howard TA. Elevated numbers of gamma delta(γδ+)T lymphocytes in children with immune thrombocytopenic purpura. J Clin Immunol 1994;14:237-47. (Pubitemid 24257257)
8. Crossley AR, Dickinson AM, Proctor SJ, Calvert JE. Effects of interferon-α therapy on immune parameters in immune thrombocytopenic purpura. Autoimmunity 1996;24:81-100. (Pubitemid 26413862)
9. Erduran E, Aslan Y, Aliyazicioglu Y, Mocan H, Gedik Y. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Am J Hematol 1998;57:119-23.
10. Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, et al. High Th1/Th2 ratio in patients with chronic autoimmune thrombocytopenic purpura. Eur J Haematol 2003;71:283-8. (Pubitemid 37174699)
11. Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004;103:2645-7. (Pubitemid 38393019)
12. Wali YA, Al Lamki Z, Shah W, Zacharia M, Hassan A. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2002;19:329-35. (Pubitemid 34633367)
13. Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003;349:831-6. (Pubitemid 37025402)
14. Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 2004;83:764-8. (Pubitemid 39485547)
15. George JN, Woolf SH, Raskob GE. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med 1998;30:38-44.
16. British Committee for Standards in Haematology. General Haematology Task Force: Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.
17. Gutierrez-Espindola GR, Morales-Polanco MR, Guerrero-Rivera S, Talavera JO, Sanchez-Valle E, Gomez-Morales E, et al. High doses of dexamethasone in adult patients with idiopathic thrombocytopenic purpura. Arch Med Res 2003;34:31-4. (Pubitemid 36216338)
18. Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura. A GIMEMA experience. Blood 2007;109(4):1401-7. (Pubitemid 46239570)
19. Andersson J. Cytokines in idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998;424:61-4. (Pubitemid 28410864)
20. Yoshimura C, Nomura S, Nagahama M, Ozaki Y, Kagawa H, Fukuhara S. Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. Eur J Haematol 2000;64:219-24. (Pubitemid 30186778)
21. Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H. A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol 2000;79:507-13.
22. Andersson PO, Olsson A, Wadenvik H. Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura. Br J Haematol 2002;116:862-7. (Pubitemid 34227008)
23. Jackson M, Ahmad Y, Bruce IN, Coupes B, Brenchley PE. Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus. Arthritis Res 2006;8:R81.
24. Agarwal SK, Marshall GD Jr. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001;21:147-55. (Pubitemid 32679482)
25. Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, et al. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 2005;90:914-23. (Pubitemid 41020294)
26. Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ. The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 1995;37:C331.
27. Peng J, Liu CF, Liu D, Ren C, Li W, Wang Z, et al. Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood 2003;101:2721-6. (Pubitemid 36857635)
28. + lymphocytes by inhibiting IL-12 production. J Immunol 1998;160:2231-7.